{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:50:20Z","timestamp":1649073020565},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s13721-021-00307-5","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T18:03:53Z","timestamp":1620237833000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CHD3\/4\/5\/6\/8 serve as potential prognostic predictors in human gastric cancer"],"prefix":"10.1007","volume":"10","author":[{"given":"Lijun","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"307_CR1","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1016\/j.celrep.2017.11.021","volume":"21","author":"S Badodi","year":"2017","unstructured":"Badodi S et al (2017) Convergence of BMI1 and CHD7 on ERK signaling in medulloblastoma. Cell Rep 21:2772\u20132784. https:\/\/doi.org\/10.1016\/j.celrep.2017.11.021","journal-title":"Cell Rep"},{"key":"307_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"307_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S (2017) UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19:649\u2013658. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002","journal-title":"Neoplasia"},{"key":"307_CR4","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/1878-0261.12104","volume":"11","author":"X Chu","year":"2017","unstructured":"Chu X, Guo X, Jiang Y, Yu H, Liu L, Shan W, Yang ZQ (2017) Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers\u2014initial evidence of an oncogenic role for CHD7. Mol Oncol 11:1348\u20131360. https:\/\/doi.org\/10.1002\/1878-0261.12104","journal-title":"Mol Oncol"},{"key":"307_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","volume":"78","author":"CR Clapier","year":"2009","unstructured":"Clapier CR, Cairns BR (2009) The biology of chromatin remodeling complexes. Annu Rev Biochem 78:273\u2013304. https:\/\/doi.org\/10.1146\/annurev.biochem.77.062706.153223","journal-title":"Annu Rev Biochem"},{"key":"307_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R et al (2015) Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med 21:449\u2013456. https:\/\/doi.org\/10.1038\/nm.3850","journal-title":"Nat Med"},{"key":"307_CR7","doi-asserted-by":"publisher","first-page":"80901","DOI":"10.18632\/oncotarget.12646","volume":"7","author":"C D'Alesio","year":"2016","unstructured":"D\u2019Alesio C et al (2016) RNAi screens identify CHD4 as an essential gene in breast cancer growth. Oncotarget 7:80901\u201380915. https:\/\/doi.org\/10.18632\/oncotarget.12646","journal-title":"Oncotarget"},{"key":"307_CR8","doi-asserted-by":"publisher","DOI":"10.1242\/bio.038323","author":"C D'Alesio","year":"2019","unstructured":"D\u2019Alesio C et al (2019) The chromodomain helicase CHD4 regulates ERBB2 signaling pathway and autophagy in ERBB2(+) breast cancer cells. Biol Open. https:\/\/doi.org\/10.1242\/bio.038323","journal-title":"Biol Open"},{"key":"307_CR9","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"key":"307_CR10","first-page":"3697","volume":"11","author":"B Guan","year":"2018","unstructured":"Guan B, Ran XG, Du YQ, Ren F, Tian Y, Wang Y, Chen MM (2018) High CHD9 expression is associated with poor prognosis in clear cell renal cell carcinoma. Int J Clin Exp Pathol 11:3697\u20133702","journal-title":"Int J Clin Exp Pathol"},{"key":"307_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/ng.907","volume":"43","author":"Y Gui","year":"2011","unstructured":"Gui Y et al (2011) Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 43:875\u2013878. https:\/\/doi.org\/10.1038\/ng.907","journal-title":"Nat Genet"},{"key":"307_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1139\/o07-063","volume":"85","author":"JA Hall","year":"2007","unstructured":"Hall JA, Georgel PT (2007) CHD proteins: a diverse family with strong ties. Biochem Cell Biol 85:463\u2013476. https:\/\/doi.org\/10.1139\/o07-063","journal-title":"Biochem Cell Biol"},{"key":"307_CR13","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3892\/ol.2019.11138","volume":"19","author":"T Hashimoto","year":"2020","unstructured":"Hashimoto T et al (2020) Clinical significance of chromatin remodeling factor CHD5 expression in gastric cancer. Oncol Lett 19:1066\u20131073. https:\/\/doi.org\/10.3892\/ol.2019.11138","journal-title":"Oncol Lett"},{"key":"307_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1365-2559.2011.03819.x","volume":"58","author":"MS Kim","year":"2011","unstructured":"Kim MS, Chung NG, Kang MR, Yoo NJ, Lee SH (2011) Genetic and expressional alterations of CHD genes in gastric and colorectal cancers. Histopathology 58:660\u2013668. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.03819.x","journal-title":"Histopathology"},{"key":"307_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mrfmmm.2006.07.012","volume":"618","author":"CG Marfella","year":"2007","unstructured":"Marfella CG, Imbalzano AN (2007) The Chd family of chromatin remodelers. Mutat Res 618:30\u201340. https:\/\/doi.org\/10.1016\/j.mrfmmm.2006.07.012","journal-title":"Mutat Res"},{"key":"307_CR16","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1038\/s41598-019-40327-w","volume":"9","author":"LD McKenzie","year":"2019","unstructured":"McKenzie LD et al (2019) CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma. Sci Rep 9:4444. https:\/\/doi.org\/10.1038\/s41598-019-40327-w","journal-title":"Sci Rep"},{"key":"307_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026450","author":"AA Mills","year":"2017","unstructured":"Mills AA (2017) The chromodomain helicase DNA-binding chromatin remodelers: family traits that protect from and promote cancer. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a026450","journal-title":"Cold Spring Harb Perspect Med"},{"key":"307_CR18","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1158\/0008-5472.Can-14-0013","volume":"74","author":"D Mouradov","year":"2014","unstructured":"Mouradov D et al (2014) Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. Cancer Res 74:3238\u20133247. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-0013","journal-title":"Cancer Res"},{"key":"307_CR19","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/onc.2008.440","volume":"28","author":"P Nagarajan","year":"2009","unstructured":"Nagarajan P, Onami TM, Rajagopalan S, Kania S, Donnell R, Venkatachalam S (2009) Role of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesis. Oncogene 28:1053\u20131062. https:\/\/doi.org\/10.1038\/onc.2008.440","journal-title":"Oncogene"},{"key":"307_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/onc.2016.172","volume":"36","author":"ML Nickerson","year":"2017","unstructured":"Nickerson ML et al (2017) Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response. Oncogene 36:35\u201346. https:\/\/doi.org\/10.1038\/onc.2016.172","journal-title":"Oncogene"},{"key":"307_CR21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jhep.2015.06.009","volume":"63","author":"K Nio","year":"2015","unstructured":"Nio K et al (2015) Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma. J Hepatol 63:1164\u20131172. https:\/\/doi.org\/10.1016\/j.jhep.2015.06.009","journal-title":"J Hepatol"},{"key":"307_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR et al (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6:1\u20136. https:\/\/doi.org\/10.1016\/s1476-5586(04)80047-2","journal-title":"Neoplasia"},{"key":"307_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1182\/blood-2014-10-604959","volume":"126","author":"D Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez D et al (2015) Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia. Blood 126:195\u2013202. https:\/\/doi.org\/10.1182\/blood-2014-10-604959","journal-title":"Blood"},{"key":"307_CR24","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3892\/or.2013.2597","volume":"30","author":"G Sawada","year":"2013","unstructured":"Sawada G et al (2013) CHD8 is an independent prognostic indicator that regulates Wnt\/\u03b2-catenin signaling and the cell cycle in gastric cancer. Oncol Rep 30:1137\u20131142. https:\/\/doi.org\/10.3892\/or.2013.2597","journal-title":"Oncol Rep"},{"key":"307_CR25","doi-asserted-by":"publisher","first-page":"49322","DOI":"10.18632\/oncotarget.10337","volume":"7","author":"AM Sz\u00e1sz","year":"2016","unstructured":"Sz\u00e1sz AM et al (2016) Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget 7:49322\u201349333. https:\/\/doi.org\/10.18632\/oncotarget.10337","journal-title":"Oncotarget"},{"key":"307_CR26","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45:W98-w102. https:\/\/doi.org\/10.1093\/nar\/gkx247","journal-title":"Nucleic Acids Res"},{"key":"307_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41556-018-0258-1","volume":"21","author":"AM Valencia","year":"2019","unstructured":"Valencia AM, Kadoch C (2019) Chromatin regulatory mechanisms and therapeutic opportunities in cancer. Nat Cell Biol 21:152\u2013161. https:\/\/doi.org\/10.1038\/s41556-018-0258-1","journal-title":"Nat Cell Biol"},{"issue":"Suppl 5","key":"307_CR28","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/annonc\/mdr284","volume":"22","author":"E Van Cutsem","year":"2011","unstructured":"Van Cutsem E et al (2011) The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO\/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol 22(Suppl 5):v1\u2013v9. https:\/\/doi.org\/10.1093\/annonc\/mdr284","journal-title":"Ann Oncol"},{"key":"307_CR29","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B (2018) LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res 46:D956-d963. https:\/\/doi.org\/10.1093\/nar\/gkx1090","journal-title":"Nucleic Acids Res"},{"key":"307_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/nar\/gkg034","volume":"31","author":"C von Mering","year":"2003","unstructured":"von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B (2003) STRING: a database of predicted functional associations between proteins. Nucleic Acids Res 31:258\u2013261. https:\/\/doi.org\/10.1093\/nar\/gkg034","journal-title":"Nucleic Acids Res"},{"key":"307_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1423-0127-16-95","volume":"16","author":"X Wang","year":"2009","unstructured":"Wang X, Lau KK, So LK, Lam YW (2009) CHD5 is down-regulated through promoter hypermethylation in gastric cancer. J Biomed Sci 16:95. https:\/\/doi.org\/10.1186\/1423-0127-16-95","journal-title":"J Biomed Sci"},{"key":"307_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3892\/ijmm.2017.3225","volume":"41","author":"G Xu","year":"2018","unstructured":"Xu G, Zhu H, Zhang M, Xu J (2018a) Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5. Int J Mol Med 41:155\u2013163. https:\/\/doi.org\/10.3892\/ijmm.2017.3225","journal-title":"Int J Mol Med"},{"key":"307_CR33","doi-asserted-by":"publisher","first-page":"e7588","DOI":"10.1590\/1414-431x20187588","volume":"51","author":"L Xu","year":"2018","unstructured":"Xu L, Peng H, Huang XX, Xia YB, Hu KF, Zhang ZM (2018b) Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer. Braz J Med Biol Res 51:e7588. https:\/\/doi.org\/10.1590\/1414-431x20187588","journal-title":"Braz J Med Biol Res"},{"key":"307_CR34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12885-020-06762-z","volume":"20","author":"N Xu","year":"2020","unstructured":"Xu N et al (2020) CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA\/ROCK pathway by regulating PHF5A. BMC Cancer 20:262. https:\/\/doi.org\/10.1186\/s12885-020-06762-z","journal-title":"BMC Cancer"},{"key":"307_CR35","doi-asserted-by":"publisher","first-page":"13099","DOI":"10.18632\/oncotarget.14402","volume":"8","author":"H Yu","year":"2017","unstructured":"Yu H, Jiang Y, Liu L, Shan W, Chu X, Yang Z, Yang ZQ (2017) Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer. Oncotarget 8:13099\u201313115. https:\/\/doi.org\/10.18632\/oncotarget.14402","journal-title":"Oncotarget"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-021-00307-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13721-021-00307-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-021-00307-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T08:32:38Z","timestamp":1639038758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13721-021-00307-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1007\/s13721-021-00307-5","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"value":"2192-6662","type":"print"},{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]},"assertion":[{"value":"30 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"34"}}